Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mednow Inc MDNWF

Mednow Inc. is a Canada-based healthcare technology company, which offers virtual access with a high standard of care. The Company provides virtual pharmacy and telemedicine services, as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. The Company’s services include free at-home delivery of medications, doctor... see more

Recent & Breaking News (GREY:MDNWF)

Mednow Announces Partnership With Medcan Health Management Inc. to Deliver Collaborative, Interdisciplinary Healthcare

Business Wire May 17, 2023

Mednow Announces a Partnership with Next Level Benefits to Offer its Services to their Clients and Plan Members; Announces the Ongoing Process to Wind-Down Select Subsidiaries

Business Wire May 16, 2023

Mednow Announces Closing of Prospectus Supplement Financing Led by Gravitas Securities and Concurrent Non-brokered Private Placement for Aggregate Proceeds of $1.1 Million

Business Wire May 15, 2023

Mednow Announces Filing of Prospectus Supplement

Business Wire May 11, 2023

Mednow Announces Amendment to Terms of Prospectus Supplement Offering

Business Wire May 9, 2023

Mednow Announces the Execution of Cost Reductions Through the Wind-Down of Two Subsidiaries

Business Wire May 9, 2023

Mednow Announces Cost Reductions Through Efficiencies and Streamlining of Business Lines

Business Wire May 2, 2023

Mednow Releases Multiple Updates to Its IOS, Android and Web Based Applications, Including Pharmacist Led In-App Prescribing, Clinical Services Flows, and Single Sign-On for Seamless Patient and Partner Experiences

Business Wire April 26, 2023

IIROC Trading Resumption - MNOW

Canada NewsWire April 24, 2023

Mednow Announces Financing by Way of Prospectus Supplement for Proceeds of up to $1,000,000 Led by Gravitas Securities

Business Wire April 24, 2023

IIROC Trading Halt - MNOW

Canada NewsWire April 24, 2023

Mednow (TSXV:MNOW) announces PBAS partnership

Maor Kagan April 24, 2023

Mednow announces PBAS partnership.

Business Wire April 24, 2023

Mednow Achieves Record Q2 2023 Financial Results with Quarterly Revenue of $11.3 Million; 17% Q/Q Revenue Growth and 466% Y/Y Revenue Growth; Adjusted EBITDA Improved 32% Y/Y; and Cash Flow from Operations Improved by 7% Q/Q

Business Wire March 31, 2023

Mednow to Host Quarterly Conference Call on Friday, March 31, 2023, at 8:30am EST on its Second-Quarter 2023 Financial Results

Business Wire March 28, 2023

PARVIS INVEST INC. AND GRAVITAS II CAPITAL CORP. RECEIVE CONDITIONAL APPROVAL OF REVERSE TAKEOVER TRANSACTION AND FILE FILING STATEMENT

PR Newswire March 2, 2023

Mednow Inc. to Present at the Gravitas 6th Annual Growth Conference

Business Wire February 24, 2023

Mednow releases Caregiver feature suite in its latest product update for the company's web, IOS and Android applications; Mednow announces completion of Convertible Debenture Financing

Business Wire February 21, 2023

Mednow Announces Closing of First Tranche of Senior Secured Convertible Debenture Financing Led by Mednow Management

Business Wire February 8, 2023

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Business Wire February 2, 2023